Palliative treatment of malignant obstructive jaundice by intra-aortic infusion chemotherapy

M. C. Sheen, J. Y. Wang, Yi-Wen Wang

Research output: Contribution to journalArticle

Abstract

Between Jan. 1983 and Dec. 1991, thirty two patients with biliary obstruction caused by hepatocellular carcinoma (n=15); metastases to the liver or lymph nodes adjacent to the porta hepatis from various primaries (n=10) and tumors arising in the periampular area (n=7) not suitable to other conventional therapy, were treated with subselective intra-aortic chemotherapy. The catheter was inserted retrogradely through the lateral circumflex artery into the aorta. The catheter tip was placed proximal to the branching of the celiac artery. Of all 32 patients treated 18 patients (56 %) exhibited a decrease in bilirubin levels (total/direct) from a mean of 16.5/9.5 mg/dl to 4.3/2.2 mg/dl, and a decrease in alkaline phosphatase from a mean of 476 IU to 234 IU. The survival time for responders varied from 1.5 to 17.8 months with a median of 5.2 months. Four out of five patients with percutaneous transhepatic biliary drainage, which failed to relieve jaundice, were successful in declining bilirubin and alkaline phosphatase levels by this therapy. The side effects were mild and tolerable. This therapeutic modality is a simple and effective alternative method for palliation of malignant obstructive jaundice.

Original languageEnglish
Pages (from-to)26-30
Number of pages5
JournalRegional Cancer Treatment
Volume6
Issue number1
Publication statusPublished - 1993 Jan 1

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pharmacology

Fingerprint Dive into the research topics of 'Palliative treatment of malignant obstructive jaundice by intra-aortic infusion chemotherapy'. Together they form a unique fingerprint.

  • Cite this